(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PENTARLANDIR

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

PENTARLANDIR

ST13

US500000090067787

Class

5

Filing

90067787

Registration

6466692

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

17

Latest update

08/31/2021

Trademark type

Word

Nice classes

5

Filing date

07/22/2020

Registration date

08/31/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/31/2021

Last transaction

08/31/2021

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

4

Owner type

03

Owner location

NEW TAIPEI CITY 22175, TW

Examiner

WILSON, MARYNELLE WEST

Law office

M40

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

SyneuRx International (Taiwan) Corp.

Representatives

Michael T. Smith BIRCH STEWART KOLASCH & BIRCH LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Acids for pharmaceutical purposesaromatic acids for the treatment of viral infection; antibiotics; viral antibiotics; cachets for pharmaceutical purposescachets filled with aromatic acids for the treatment of viral infection; cachou for pharmaceutical purposescachou filled with aromatic acids for the treatment of viral infection; candymedicated; candy for medical purposes; capsules filled with aromatic acids for the treatment of viral infection; chemical preparations for pharmaceutical purposes for the treatment of viral infection; chemical preparations for medical purposes for the treatment of viral infection; chemical preparations for veterinary purposes for the treatment of viral infection; chemical reagents for medical or veterinary purposes; chemico-pharmaceutical preparations for the treatment of viral infection; chewing gum for medical purposes; dietetic foods adapted for medical purposes; dietetic beverages adapted for medical purposes; dietetic injection and dietetic infusion adapted for medical use; drugs for medical purposes for the treatment of viral infection; flour for pharmaceutical purposes; meal for pharmaceutical purposes; freeze-dried food adapted for medical purposes; lyophilized food adapted for medical purposes; germicides; gum for medical purposes for the treatment of viral infection; homogenized food adapted for medical purposes; medicated animal feed; medicated dentifrices; medicinal infusions for the treatment of viral infection; medicines for human purposes for treatment of viral infection; medicines for veterinary purposes for treatment of viral infection; preparations being cultures of microorganisms for medical or veterinary use; nervines; nutraceutical preparations for treatment of viral infection; nutritional supplements; ointments for treatment of viral infection; cough pastilles for pharmaceutical purposes; cough lozenges for pharmaceutical purposes; pectin for pharmaceutical purposes for treatment of viral infection; pharmaceutical preparations for treatment of viral infection; pharmaceuticals for treatment of viral infection; poultices; pre-filled syringes filled with aromatic acids for the treatment of viral infection; aromatic acid salts for the treatment of viral infection; sedatives; tranquillizers; suppositories for treatment of viral infection; syrups for pharmaceutical purposes for treatment of viral infection; medicated tonics for the treatment of viral infection; inhalation devicesinhalers filled with aromatic acids for the treatment of viral infection; drugs for pulmonary administration for the treatment of viral infection

Publications

History of USPTO decisions and trademark events.

17 publications found

R.PR

REGISTERED-PRINCIPAL REGISTER

08/31/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/15/2021

PUBO

PUBLISHED FOR OPPOSITION

06/15/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/26/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/10/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/27/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/27/2021

ALIE

ASSIGNED TO LIE

04/27/2021

AMPX

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

04/06/2021

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

04/06/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/16/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

11/12/2020

GNRT

NON-FINAL ACTION E-MAILED

11/12/2020

CNRT

NON-FINAL ACTION WRITTEN

11/12/2020

DOCK

ASSIGNED TO EXAMINER

11/05/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/19/2020

NWAP

NEW APPLICATION ENTERED

07/25/2020

Continuous trademark protection

Get notified about every new filing that threatens PENTARLANDIR or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.